Forward Thinkers Review
In the report, Forward Thinkers Review, top experts and key opinion leaders from the Nordic pharma industry share insights into how savvy life science businesses can ensure strong, continuous growth over the next 3-5 years.
Close to 200 respondents representing top managers and commercial functions in the pharmaceutical industry in the Nordic region, as well as actors from e.g. authorities, have participated through interviews and questionnaires. A comprehensive data set forms the basis for the conclusions of Forward Thinkers Review, published together with our Nordic partners DLIMI and Atrium.
Four trends crucial to success
The report points to four trends that will be crucial to success in the industry on a 3-5 year horizon:
- The use of health data (Real World Data) in decision-making about e.g. treatments
- The influence of digital treatment models, e.g. for prevention
- Collaboration between the pharmaceutical industry and the public healthcare system
- Centralisation of drug management and reduction in national budgets.
The report suggests paths on how to transform these trends from being challenges to becoming success parameters. In doing so, you mush rethink both ways of organising and the roles and competencies that are needed.
Forward Thinkers Review 2022
How to succeed in the Nordic Pharma Markets
With the report Forward Thinkers Review, we take the temperature of the pharma industry in the Nordics and focus on opportunities and challenges over the next 3-5. Extensive change calls for new thinking, and the report indicates must-win battles.